MARKET OVERVIEW:
The global trehalose market size was valued at USD 169 million in 2024. The market is projected to grow from USD 181 million in 2025 to USD 272 million by 2032, exhibiting a CAGR of 7.2% during the forecast period.
Trehalose (C12H22O11) is a naturally occurring disaccharide composed of two glucose molecules linked by a 1,1-glucoside bond. This white crystalline powder serves as a versatile sugar substitute due to its mild sweetness and stability under extreme conditions. While trehalose is widely utilized across food, pharmaceutical, and cosmetic applications, food-
MARKET INSIGHT & GROWTH DRIVERS:
USD 169 million USD 181 million 7.2% Click Here for More Detailed
The market growth is driven by increasing demand from the health food and pharmaceutical sectors, particularly for joint health supplements
MARKET DYNAMICS
Growing Demand for Sugar Alternatives to Propel Trehalose Market Growth
The global shift toward healthier lifestyles and reduced sugar consumption is accelerating demand for alternative sweeteners like trehalose. As consumers become increasingly aware of the health risks associated with high sugar intake, trehalose has emerged as a viable substitute due to its comparable sweetness level (45% of sucrose) while offering additional functional benefits. Unlike traditional sugars, trehalose does not significantly impact blood glucose levels, making it particularly appealing to diabetic consumers. The food and beverage industry's transition toward cleanlabel ingredients further strengthens trehalose
MARKET OPPORTUNITIES
The biopharmaceutical industry's rapid growth presents substantial opportunities for trehalose suppliers. Its cryoprotective properties make it ideal for stabilizing sensitive biological materials during lyophilization - a critical process for many injectable drugs and vaccines. With the global lyophilization market projected to grow significantly to meet increasing biologics demand, trehalose stands to benefit substantially. Pharmaceutical manufacturers are increasingly specifying trehalose in their formulations due to its superior stabilization performance compared to alternatives.
COMPANY MISSION
Boron neutron capture therapy (BNCT) is emerging as a promising cancer treatment modality, particularly for difficult-to-treat tumors like glioblastoma. Japan has led clinical adoption with over 200 patients treated since 2020, while China and Europe are ramping up clinical trials. The precision targeting capability of boron-10, when irradiated with low-energy neutrons, minimizes damage to healthy tissues - a significant advantage over conventional radiotherapy. Pharmaceutical companies are investing in boron-containing drug development, with several boron-10 based compounds currently in Phase II/III trials for various oncology indications.
REGIONAL MARKET OUTLOOK
North America
The North American trehalose market is driven by strong demand from the food and pharmaceutical sectors, with the U.S. leading in consumption.
Growing health awareness has increased the adoption of trehalose as a sugar substitute in functional foods and beverages. The region's strict FDA regulations regarding food additives and pharmaceutical-grade ingredients ensure high-quality production standards. However, market growth is somewhat restrained by the presence of alternative sweeteners like stevia and erythritol. Despite this, the pharmaceutical industry's focus on stabilizing biologics and vaccines presents significant opportunities for trehalose applications.
Europe
Europe represents the second-largest market for trehalose, with stringent EU food safety regulations influencing product quality and applications. The region sees rising demand in bakery, confectionery, and dairy products as consumers shift toward natural sweeteners. Pharmaceutical applications are also growing, particularly in biopharmaceutical stabilization. Germany and France lead regional consumption, supported by well-established food processing and pharmaceutical industries. High production costs remain a challenge, but innovation in extraction and synthesis technologies is helping
COMPETITIVE LANDSCAPE
• Hayashibara Co., Ltd. (Japan)
• Meihua Holdings Group Co., Ltd. (China)
• Lianmeng Chemical Group (China)
• Shandong Fuyang Biotechnology Co., Ltd. (China)
• Sinozyme Biotechnology Co., Ltd. (China)
• Jiangsu OGO Biotech Co., Ltd. (China)
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
• Baolingbao Biology Co., Ltd. (China)
DOWNLOAD FREE SAMPLE PDF
About Us
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights
